We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Tomatoes Contain a Nutrient that Prevents Vascular Diseases

By LabMedica International staff writers
Posted on 17 Jan 2011
Print article
A new study had discovered that tomatoes contain 9-oxo-octadecadienoic (9-oxo-ODA), a nutrient with antidyslipidemic affects that could help tackle the onset of vascular diseases.

Researchers from Kyoto University (Japan) conducted a study to identify beneficial compounds that could improve abnormalities of lipid metabolism, primarily as part of an effort to find extracts which tackle dyslipidemia, a condition which is caused by an abnormal amount of lipids--such as cholesterol or fat--in the blood stream. They focused on the activation of peroxisome proliferator-activated receptor (PPAR ) and attempted to detect compounds that activate PPAR in tomatoes. To do so, the researchers screened fractions of tomato extracts using PPAR luciferase reporter assay, and found one fraction, rechromatographed-fraction eluted in 57 min (RF57), that significantly increased PPAR reporter activity.

They found that RF57 fraction significantly increased the mRNA expression levels of PPAR target genes involved in fatty acid oxidation and O2 consumption in mouse primary hepatocytes, and inhibited cellular triglyceride accumulation. Based on liquid chromatography-mass spectrometry (LC/MS) and nuclear magnetic resonance (NMR) analyses, the researchers then determined the chemical structure of the active compound in RF57 as 9-oxo-ODA. The study was published early online on January 7, 2011, in Molecular Nutrition & Food Research.

"Finding a compound which helps the prevention of obesity-related chronic diseases in foodstuffs is a great advantage to tackling these diseases," said lead author Teruo Kawada, PhD, of the laboratory of molecular function of food, and colleagues. "It means that the tomato allows people to easily manage the onset of dyslipidemia through their daily diet."

Tomatoes contain large amounts of vitamin C, providing 40% of the daily value (DV). They also contain 15% DV of vitamin A, 8% DV of potassium, and 7% of the recommended dietary allowance (RDA) of iron for women and 10% RDA for men. The red pigment contained in tomatoes is called lycopene, which acts as an antioxidant, neutralizing free radicals. A study by Harvard researchers found that men who consumed 10 servings of tomatoes a week could cut the risk of developing prostate cancer by 45%, while 7 servings of raw tomatoes lower the risk of developing rectal colon or stomach cancers by 60%.

Related Links:
Kyoto University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.